Genexine, Inc. (095700.KQ)

KRW 5590.0

(-3.79%)

Operating Expenses Summary of Genexine, Inc.

  • Genexine, Inc.'s latest annual operating expenses in 2023 was 41.62 Billion KRW , down -9.08% from previous year.
  • Genexine, Inc.'s latest quarterly operating expenses in 2024 Q2 was 5.36 Billion KRW , down -52.25% from previous quarter.
  • Genexine, Inc. reported a annual operating expenses of 41.71 Billion KRW in annual operating expenses 2022, down -23.63% from previous year.
  • Genexine, Inc. reported a annual operating expenses of 54.62 Billion KRW in annual operating expenses 2021, up 2.65% from previous year.
  • Genexine, Inc. reported a quarterly operating expenses of 11.23 Billion KRW for 2024 Q1, up 515.08% from previous quarter.
  • Genexine, Inc. reported a quarterly operating expenses of 11.1 Billion KRW for 2023 Q2, up 5.84% from previous quarter.

Annual Operating Expenses Chart of Genexine, Inc. (2023 - 2012)

Historical Annual Operating Expenses of Genexine, Inc. (2023 - 2012)

Year Operating Expenses Operating Expenses Growth
2023 41.62 Billion KRW -9.08%
2022 41.71 Billion KRW -23.63%
2021 54.62 Billion KRW 2.65%
2020 53.21 Billion KRW 1.98%
2019 52.18 Billion KRW 10.94%
2018 47.03 Billion KRW 7.14%
2017 43.9 Billion KRW 19.88%
2016 36.62 Billion KRW 59.28%
2015 22.99 Billion KRW 0.0%
2012 7.07 Billion KRW 0.0%

Peer Operating Expenses Comparison of Genexine, Inc.

Name Operating Expenses Operating Expenses Difference
HLB Co., Ltd. 109.98 Billion KRW 62.152%
iNtRON Biotechnology, Inc. 7.84 Billion KRW -430.579%
BINEX Co., Ltd. 55.67 Billion KRW 25.231%
Bioneer Corporation 204.55 Billion KRW 79.65%
Anterogen.Co.,Ltd. 7.74 Billion KRW -437.821%
MEDIPOST Co., Ltd. 65.31 Billion KRW 36.265%
CrystalGenomics, Inc. 32.36 Billion KRW -28.602%
Helixmith Co., Ltd 37.36 Billion KRW -11.403%
Chabiotech Co.,Ltd. 285.93 Billion KRW 85.442%
Medy-Tox Inc. 110.88 Billion KRW 62.458%
Peptron, Inc. 16.65 Billion KRW -149.921%
Amicogen, Inc. 52.82 Billion KRW 21.193%
HLB Therapeutics Co.,Ltd. 16.16 Billion KRW -157.498%
LegoChem Biosciences, Inc. 98.61 Billion KRW 57.789%
ALTEOGEN Inc. 40.93 Billion KRW -1.693%
PharmaResearch Co., Ltd. 89.44 Billion KRW 53.457%
SillaJen, Inc. 5.11 Billion KRW -714.286%
JETEMA, Co., Ltd. 25.66 Billion KRW -62.203%
OliX Pharmaceuticals,Inc 35.24 Billion KRW -18.096%
Genomictree Inc. 16.26 Billion KRW -155.94%
MedPacto, Inc. 26.91 Billion KRW -54.641%
D&D Pharmatech 32.16 Billion KRW -29.428%
EASY BIO,Inc. 29.67 Billion KRW -40.295%
GI Innovation, Inc. 57.59 Billion KRW 27.72%